dicyclomine - CISMeF

Preferred Label : dicyclomine;

MeSH definition : A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms.;

MeSH synonym : dicycloverin;

CISMeF synonym : 67-92-5 (Dicyclomine hydrochloride); atlantis brand of dicyclomine hydrochloride; aventis behring brand of dicyclomine hydrochloride; aventis brand of dicyclomine hydrochloride; florizel brand of dicyclomine hydrochloride; hauck brand of dicyclomine hydrochloride; hoechst brand of dicyclomine hydrochloride; ortega brand of dicyclomine hydrochloride; pasadena brand of dicyclomine hydrochloride; riva brand of dicyclomine hydrochloride; sigma brand of dicyclomine hydrochloride; vangard brand of dicyclomine hydrochloride; vortech brand of dicyclomine hydrochloride;

MeSH hyponym : lomine; diclomin; dibent; spascol; bentyl; merbentyl; Di-Spaz; bentylol; OR-Tyl; Di-Cyclonex; dicyclomine hydrochloride; Hydrochloride, Dicyclomine; Di Spaz; OR Tyl; Di Cyclonex;

MeSH CAS label : (1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(diethylamino)ethyl ester;

MeSH Related Number : dicyclomine hydrochloride; 67-92-5 (hydrochloride); 77-19-0 (Dicyclomine); CQ903KQA31;

Registry Number MeSH : 77-19-0;

Related CAS MeSH : CQ903KQA31 (Dicyclomine hydrochloride);

Codes EINECS : 201-009-4;

Is substance : O;

UNII : 4KV4X8IF6V;

InChIKey : CURUTKGFNZGFSE-UHFFFAOYSA-N;

Details

Origin ID

D004025;

UMLS CUI

C0012125;

ATC code(s)
- dicycloverine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- dicyclomine [Substance BNPC]
Currated CISMeF NLP mapping
- Dicyclomine [LOINC component]
- Dicyclomine [ICHI extension code]
- Dicyclomine [NCIt concept]
- Dicycloverine [ICD-11 Extension code]
- Dicycloverine (substance) [SNOMED CT concept]
- Product containing dicycloverine (medicinal product) [SNOMED CT concept]
- dicyclomine [SNOMED Notion]
Pharmacological action(s)
- muscarinic antagonists [MeSH Descriptor]
- parasympatholytics [MeSH Descriptor]
- peripheral nervous system agents [MeSH Descriptor]
Record concept(s)
- Di-Cyclonex [MeSH concept]
- Di-Spaz [MeSH concept]
- OR-Tyl [MeSH concept]
- bentyl [MeSH concept]
- bentylol [MeSH concept]
- dibent [MeSH concept]
- diclomin [MeSH concept]
- dicyclomine [MeSH concept]
- dicyclomine hydrochloride [MeSH concept]
- lomine [MeSH concept]
- merbentyl [MeSH concept]
- spascol [MeSH concept]
Related MeSH Supplementary Concept(s)
- dicyclomine, doxylamine, pyridoxine drug combination [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Dicyclomine [NCIt concept]
- Dicyclomine [LOINC component]
- Dicycloverine [ICD-11 Extension code]
- Dicycloverine (substance) [SNOMED CT concept]
- Product containing dicycloverine (medicinal product) [SNOMED CT concept]
- dicyclomine [Substance BNPC]
- dicyclomine [SNOMED Notion]
- dicycloverine [ATC Code]
Validated automatic mappings to BTNT
- dicycloverine [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients